IMAX IMAX | $43.21 -0.4% | 7/24/2026 | | Boost Price Target | $46.00 ➝ $54.00 | Outperform | 00.00% | View details for Wedbush rating of IMAX (NYSE:IMAX) on 7/24/2026 |
INTC Intel | $92.32
| 7/24/2026 | | Boost Price Target | $60.00 ➝ $98.00 | Neutral | 00.00% | View details for Wedbush rating of Intel (NASDAQ:INTC) on 7/24/2026 |
NVCR NovoCure | $17.65
| 7/24/2026 | | Boost Price Target | $18.00 ➝ $20.00 | Neutral | 00.00% | View details for Wedbush rating of NovoCure (NASDAQ:NVCR) on 7/24/2026 |
RBLX Roblox | $47.51 -0.1% | 7/24/2026 | | Reiterated Rating | $65.00 | Outperform | 00.00% | View details for Wedbush rating of Roblox (NYSE:RBLX) on 7/24/2026 |
UBSFY UbiSoft Entertainment | $1.06
| 7/24/2026 | | Downgrade | | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of UbiSoft Entertainment (OTCMKTS:UBSFY) on 7/24/2026 |
VRSN VeriSign | $280.00
| 7/24/2026 | | Boost Price Target | $318.00 ➝ $324.00 | Outperform | 00.00% | View details for Wedbush rating of VeriSign (NASDAQ:VRSN) on 7/24/2026 |
RVMD Revolution Medicines | $189.23
| 7/23/2026 | | Boost Price Target | $181.00 ➝ $192.10 | Outperform | 00.00% | View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 7/23/2026 |
RDDT Reddit | $168.76 +0.0% | 7/23/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Wedbush rating of Reddit (NYSE:RDDT) on 7/23/2026 |
GOOGL Alphabet | $319.74
| 7/23/2026 | | Reiterated Rating | $445.00 | Outperform | 00.00% | View details for Wedbush rating of Alphabet (NASDAQ:GOOGL) on 7/23/2026 |
AMZN Amazon.com | $232.11
| 7/23/2026 | | Reiterated Rating | $293.00 | Outperform | 00.00% | View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 7/23/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
NUVB Nuvation Bio | $6.45 +0.4% | 7/23/2026 | | Reiterated Rating | $11.00 | Outperform | 00.00% | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 7/23/2026 |
LOGI Logitech International | $105.78
| 7/22/2026 | | Reiterated Rating | $135.00 | Outperform | 00.00% | View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 7/22/2026 |
STAA STAAR Surgical | $23.38
| 7/22/2026 | | Reiterated Rating | $40.00 | Outperform | 00.00% | View details for Wedbush rating of STAAR Surgical (NASDAQ:STAA) on 7/22/2026 |
U Unity Software | $28.64 +0.1% | 7/22/2026 | | Boost Price Target | $32.00 ➝ $36.00 | Outperform | 00.00% | View details for Wedbush rating of Unity Software (NYSE:U) on 7/22/2026 |
AMC AMC Entertainment | $2.29 +0.7% | 7/21/2026 | | Reiterated Rating | $3.00 ➝ $4.00 | Outperform | 00.00% | View details for Wedbush rating of AMC Entertainment (NYSE:AMC) on 7/21/2026 |
CINT CI&T | $3.11 0.0% | 7/21/2026 | | Downgrade | $7.00 ➝ $4.00 | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of CI&T (NYSE:CINT) on 7/21/2026 |
IMNM Immunome | $22.21
| 7/21/2026 | | Reiterated Rating | $31.00 | Outperform | 00.00% | View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 7/21/2026 |
SRRK Scholar Rock | $47.67
| 7/21/2026 | | Reiterated Rating | $58.00 | Outperform | 00.00% | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 7/21/2026 |
FLUT Flutter Entertainment | $101.47 +0.2% | 7/17/2026 | | Reiterated Rating | $138.00 | Outperform | 00.00% | View details for Wedbush rating of Flutter Entertainment (NYSE:FLUT) on 7/17/2026 |
NFLX Netflix | $70.09
| 7/17/2026 | | Lower Price Target | $118.00 ➝ $105.00 | Outperform | 00.00% | View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 7/17/2026 |
ABNB Airbnb | $141.10
| 7/16/2026 | | Initiated Coverage | $152.00 | Neutral | 00.00% | View details for Wedbush rating of Airbnb (NASDAQ:ABNB) on 7/16/2026 |
AMZN Amazon.com | $232.11
| 7/16/2026 | | Initiated Coverage | $293.00 | Outperform | 00.00% | View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 7/16/2026 |
BKNG Booking | $177.46
| 7/16/2026 | | Initiated Coverage | $211.00 | Outperform | 00.00% | View details for Wedbush rating of Booking (NASDAQ:BKNG) on 7/16/2026 |
CART Maplebear | $42.21
| 7/16/2026 | | Initiated Coverage | $59.00 | Outperform | 00.00% | View details for Wedbush rating of Maplebear (NASDAQ:CART) on 7/16/2026 |
CRTO Criteo | $20.44
| 7/16/2026 | | Initiated Coverage | $30.00 | Outperform | 00.00% | View details for Wedbush rating of Criteo (NASDAQ:CRTO) on 7/16/2026 |
DASH DoorDash | $172.91
| 7/16/2026 | | Initiated Coverage | $205.00 | Neutral | 00.00% | View details for Wedbush rating of DoorDash (NASDAQ:DASH) on 7/16/2026 |
DUOL Duolingo | $122.24
| 7/16/2026 | | Initiated Coverage | $139.00 | Neutral | 00.00% | View details for Wedbush rating of Duolingo (NASDAQ:DUOL) on 7/16/2026 |
EBAY eBay | $109.39
| 7/16/2026 | | Initiated Coverage | $135.00 | Outperform | 00.00% | View details for Wedbush rating of eBay (NASDAQ:EBAY) on 7/16/2026 |
ETSY Etsy | $80.74 +0.1% | 7/16/2026 | | Initiated Coverage | $80.00 | Neutral | 00.00% | View details for Wedbush rating of Etsy (NYSE:ETSY) on 7/16/2026 |
EXPE Expedia Group | $259.94
| 7/16/2026 | | Initiated Coverage | $334.00 | Outperform | 00.00% | View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 7/16/2026 |
GOOG Alphabet | $319.09
| 7/16/2026 | | Initiated Coverage | $445.00 | Outperform | 00.00% | View details for Wedbush rating of Alphabet (NASDAQ:GOOG) on 7/16/2026 |
GOOGL Alphabet | $319.74
| 7/16/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Wedbush rating of Alphabet (NASDAQ:GOOGL) on 7/16/2026 |
META Meta Platforms | $595.19
| 7/16/2026 | | Initiated Coverage | $671.00 | Neutral | 00.00% | View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 7/16/2026 |
PINS Pinterest | $22.19 +0.2% | 7/16/2026 | | Initiated Coverage | $24.00 | Neutral | 00.00% | View details for Wedbush rating of Pinterest (NYSE:PINS) on 7/16/2026 |
RDDT Reddit | $168.76 +0.0% | 7/16/2026 | | Initiated Coverage | $250.00 | Outperform | 00.00% | View details for Wedbush rating of Reddit (NYSE:RDDT) on 7/16/2026 |
STAA STAAR Surgical | $23.38
| 7/16/2026 | | Reiterated Rating | $40.00 | Outperform | 00.00% | View details for Wedbush rating of STAAR Surgical (NASDAQ:STAA) on 7/16/2026 |
UBER Uber Technologies | $66.00 +0.1% | 7/16/2026 | | Initiated Coverage | $91.00 | Outperform | 00.00% | View details for Wedbush rating of Uber Technologies (NYSE:UBER) on 7/16/2026 |
VRSN VeriSign | $280.00
| 7/16/2026 | | Initiated Coverage | $318.00 | Outperform | 00.00% | View details for Wedbush rating of VeriSign (NASDAQ:VRSN) on 7/16/2026 |
W Wayfair | $84.01 -0.2% | 7/16/2026 | | Initiated Coverage | $104.00 | Neutral | 00.00% | View details for Wedbush rating of Wayfair (NYSE:W) on 7/16/2026 |
XMTR Xometry | $86.31
| 7/16/2026 | | Initiated Coverage | $126.00 | Outperform | 00.00% | View details for Wedbush rating of Xometry (NASDAQ:XMTR) on 7/16/2026 |
The REAL Reason Trump is Invading Iran (Ad) For a moment…
Forget about Trump’s ties to Israel.
Forget about reports of Iran’s nuclear program.
Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. Click here to find out what it is. |
DNLI Denali Therapeutics | $23.11
| 7/13/2026 | | Reiterated Rating | $26.00 | Outperform | 00.00% | View details for Wedbush rating of Denali Therapeutics (NASDAQ:DNLI) on 7/13/2026 |
BIIB Biogen | $202.19
| 7/13/2026 | | Reiterated Rating | $201.00 | Neutral | 00.00% | View details for Wedbush rating of Biogen (NASDAQ:BIIB) on 7/13/2026 |
COAG Hemab Therapeutics | $47.31
| 7/13/2026 | | Reiterated Rating | $42.00 ➝ $55.00 | Outperform | 00.00% | View details for Wedbush rating of Hemab Therapeutics (NASDAQ:COAG) on 7/13/2026 |
NTLA Intellia Therapeutics | $10.73
| 7/10/2026 | | Boost Price Target | $12.00 ➝ $17.00 | Neutral | 00.00% | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 7/10/2026 |
SNDK Sandisk | $1,436.56
| 7/9/2026 | | Boost Price Target | $1,200.00 ➝ $2,000.00 | Outperform | 00.00% | View details for Wedbush rating of Sandisk (NASDAQ:SNDK) on 7/9/2026 |
VERA Vera Therapeutics | $35.45
| 7/8/2026 | | Boost Price Target | $35.00 ➝ $43.00 | Neutral | 00.00% | View details for Wedbush rating of Vera Therapeutics (NASDAQ:VERA) on 7/8/2026 |
TLX Telix Pharmaceuticals | $10.22
| 7/6/2026 | | Reiterated Rating | $22.00 | Outperform | 00.00% | View details for Wedbush rating of Telix Pharmaceuticals (NASDAQ:TLX) on 7/6/2026 |
RVMD Revolution Medicines | $189.23
| 7/2/2026 | | Boost Price Target | $165.00 ➝ $181.00 | Outperform | 00.00% | View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 7/2/2026 |
CRM Salesforce | $163.65 0.0% | 7/1/2026 | | Initiated Coverage | | Outperform | 00.00% | View details for Wedbush rating of Salesforce (NYSE:CRM) on 7/1/2026 |
PL Planet Labs PBC | $20.46 0.0% | 7/1/2026 | | Initiated Coverage | $50.00 | Outperform | 00.00% | View details for Wedbush rating of Planet Labs PBC (NYSE:PL) on 7/1/2026 |
VOYG Voyager Technologies | $25.22 -0.1% | 7/1/2026 | | Initiated Coverage | $60.00 ➝ $46.00 | Outperform | 00.00% | View details for Wedbush rating of Voyager Technologies (NYSE:VOYG) on 7/1/2026 |
ZURA Zura Bio | $5.23
| 7/1/2026 | | Reiterated Rating | $15.00 | Outperform | 00.00% | View details for Wedbush rating of Zura Bio (NASDAQ:ZURA) on 7/1/2026 |
SPCX SpaceX | $115.07
| 6/30/2026 | | Initiated Coverage | $190.00 | Outperform | 00.00% | View details for Wedbush rating of SpaceX (NASDAQ:SPCX) on 6/30/2026 |
AVAV AeroVironment | $149.51
| 6/30/2026 | | Initiated Coverage | $250.00 | Outperform | 00.00% | View details for Wedbush rating of AeroVironment (NASDAQ:AVAV) on 6/30/2026 |
AVAV AeroVironment | $149.51
| 6/30/2026 | | Initiated Coverage | $250.00 | Outperform | 00.00% | View details for Wedbush rating of AeroVironment (NASDAQ:AVAV) on 6/30/2026 |
SPCX SpaceX | $115.07
| 6/30/2026 | | Initiated Coverage | $190.00 | Outperform | 00.00% | View details for Wedbush rating of SpaceX (NASDAQ:SPCX) on 6/30/2026 |
KTOS Kratos Defense & Security Solutions | $47.35
| 6/30/2026 | | Initiated Coverage | $85.00 | Outperform | 00.00% | View details for Wedbush rating of Kratos Defense & Security Solutions (NASDAQ:KTOS) on 6/30/2026 |
ABVX Abivax | $125.70
| 6/30/2026 | | Boost Price Target | $90.00 ➝ $110.00 | Neutral | 00.00% | View details for Wedbush rating of Abivax (NASDAQ:ABVX) on 6/30/2026 |
AVAV AeroVironment | $149.51
| 6/30/2026 | | Initiated Coverage | $250.00 | Outperform | 00.00% | View details for Wedbush rating of AeroVironment (NASDAQ:AVAV) on 6/30/2026 |
KTOS Kratos Defense & Security Solutions | $47.35
| 6/30/2026 | | Initiated Coverage | $85.00 | Outperform | 00.00% | View details for Wedbush rating of Kratos Defense & Security Solutions (NASDAQ:KTOS) on 6/30/2026 |
REPL Replimune Group | $9.70
| 6/30/2026 | | Boost Price Target | $6.00 ➝ $9.00 | Neutral | 00.00% | View details for Wedbush rating of Replimune Group (NASDAQ:REPL) on 6/30/2026 |
SPCX SpaceX | $115.07
| 6/30/2026 | | Initiated Coverage | $190.00 | Outperform | 00.00% | View details for Wedbush rating of SpaceX (NASDAQ:SPCX) on 6/30/2026 |
VOYG Voyager Technologies | $25.22 -0.1% | 6/30/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Wedbush rating of Voyager Technologies (NYSE:VOYG) on 6/30/2026 |
VRDN Viridian Therapeutics | $19.27
| 6/30/2026 | | Boost Price Target | $32.00 ➝ $43.00 | Outperform | 00.00% | View details for Wedbush rating of Viridian Therapeutics (NASDAQ:VRDN) on 6/30/2026 |
KNSA Kiniksa Pharmaceuticals International | $62.84
| 6/29/2026 | | Boost Price Target | $59.00 ➝ $72.00 | Outperform | 00.00% | View details for Wedbush rating of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) on 6/29/2026 |
INFQ Infleqtion | $8.99 +0.2% | 6/26/2026 | | Initiated Coverage | $20.00 | Outperform | 00.00% | View details for Wedbush rating of Infleqtion (NYSE:INFQ) on 6/26/2026 |
INFQ Infleqtion | $8.99 +0.2% | 6/26/2026 | | Initiated Coverage | $20.00 | Outperform | 00.00% | View details for Wedbush rating of Infleqtion (NYSE:INFQ) on 6/26/2026 |
MU Micron Technology | $920.95
| 6/25/2026 | | Boost Price Target | $1,300.00 ➝ $1,400.00 | Outperform | 00.00% | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 6/25/2026 |
CBRS Cerebras Systems | $199.12
| 6/24/2026 | | Boost Price Target | $270.00 ➝ $280.00 | Outperform | 00.00% | View details for Wedbush rating of Cerebras Systems (NASDAQ:CBRS) on 6/24/2026 |
VRNS Varonis Systems | $45.74
| 6/24/2026 | | Reiterated Rating | $37.00 | Outperform | 00.00% | View details for Wedbush rating of Varonis Systems (NASDAQ:VRNS) on 6/24/2026 |
BBBY Bed Bath & Beyond | $4.97 +0.1% | 6/23/2026 | | Boost Price Target | $8.00 ➝ $10.00 | Outperform | 00.00% | View details for Wedbush rating of Bed Bath & Beyond (NYSE:BBBY) on 6/23/2026 |
TCRX TScan Therapeutics | $0.79
| 6/23/2026 | | Reiterated Rating | $5.00 | Outperform | 00.00% | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 6/23/2026 |
APGE Apogee Therapeutics | $134.28
| 6/22/2026 | | Downgrade | $135.00 | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Apogee Therapeutics (NASDAQ:APGE) on 6/22/2026 |
SIMO Silicon Motion Technology | $270.90
| 6/22/2026 | | Boost Price Target | $230.00 ➝ $400.00 | Outperform | 00.00% | View details for Wedbush rating of Silicon Motion Technology (NASDAQ:SIMO) on 6/22/2026 |
TVTX Travere Therapeutics | $57.36
| 6/22/2026 | | Boost Price Target | $55.00 ➝ $61.00 | Outperform | 00.00% | View details for Wedbush rating of Travere Therapeutics (NASDAQ:TVTX) on 6/22/2026 |
MU Micron Technology | $920.95
| 6/18/2026 | | Boost Price Target | $500.00 ➝ $1,300.00 | Outperform | 00.00% | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 6/18/2026 |
PLTR Palantir Technologies | $122.92
| 6/16/2026 | | Initiated Coverage | | Outperform | 00.00% | View details for Wedbush rating of Palantir Technologies (NASDAQ:PLTR) on 6/16/2026 |
TRIP TripAdvisor | $13.70
| 6/16/2026 | | Boost Price Target | $19.00 ➝ $20.00 | Outperform | 00.00% | View details for Wedbush rating of TripAdvisor (NASDAQ:TRIP) on 6/16/2026 |
SYRE Spyre Therapeutics | $102.13
| 6/16/2026 | | Reiterated Rating | $100.00 | Outperform | 00.00% | View details for Wedbush rating of Spyre Therapeutics (NASDAQ:SYRE) on 6/16/2026 |
ROKU Roku | $141.97
| 6/16/2026 | | Downgrade | $155.00 | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 6/16/2026 |
FLUT Flutter Entertainment | $101.47 +0.2% | 6/15/2026 | | Initiated Coverage | $138.00 | Outperform | 00.00% | View details for Wedbush rating of Flutter Entertainment (NYSE:FLUT) on 6/15/2026 |
DDOG Datadog | $246.86
| 6/15/2026 | | Initiated Coverage | | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Datadog (NASDAQ:DDOG) on 6/15/2026 |
EPAM EPAM Systems | $89.94 +0.1% | 6/15/2026 | | Initiated Coverage | $99.00 | Sector Perform ➝ Neutral | 00.00% | View details for Wedbush rating of EPAM Systems (NYSE:EPAM) on 6/15/2026 |
EPAM EPAM Systems | $89.94 +0.1% | 6/15/2026 | | Initiated Coverage | $99.00 | Sector Perform ➝ Neutral | 00.00% | View details for Wedbush rating of EPAM Systems (NYSE:EPAM) on 6/15/2026 |
FLUT Flutter Entertainment | $101.47 +0.2% | 6/15/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Wedbush rating of Flutter Entertainment (NYSE:FLUT) on 6/15/2026 |
NTLA Intellia Therapeutics | $10.73
| 6/15/2026 | | Reiterated Rating | $12.00 | Neutral | 00.00% | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 6/15/2026 |
CLYM Climb Bio | $12.84
| 6/12/2026 | | Reiterated Rating | $17.00 | Outperform | 00.00% | View details for Wedbush rating of Climb Bio (NASDAQ:CLYM) on 6/12/2026 |
DMRA Damora Therapeutics, Inc. Common Stock | $28.82
| 6/12/2026 | | Reiterated Rating | $35.00 | Outperform | 00.00% | View details for Wedbush rating of Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) on 6/12/2026 |
IDYA IDEAYA Biosciences | $35.40
| 6/12/2026 | | Reiterated Rating | $58.00 | Outperform | 00.00% | View details for Wedbush rating of IDEAYA Biosciences (NASDAQ:IDYA) on 6/12/2026 |
IMNM Immunome | $22.21
| 6/12/2026 | | Reiterated Rating | $31.00 | Outperform | 00.00% | View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 6/12/2026 |
Buy this stock today (Ad) Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7.
One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race. Get the name, ticker, and full Hotlist before markets open |
ORCL Oracle | $114.90 -0.1% | 6/11/2026 | | Lower Price Target | $275.00 ➝ $240.00 | Outperform | 00.00% | View details for Wedbush rating of Oracle (NYSE:ORCL) on 6/11/2026 |
ORCL Oracle | $114.90 -0.1% | 6/11/2026 | | Lower Price Target | $275.00 ➝ $240.00 | Outperform | 00.00% | View details for Wedbush rating of Oracle (NYSE:ORCL) on 6/11/2026 |
ARGX argenex | $918.22
| 6/11/2026 | | Reiterated Rating | $1,000.00 | Outperform | 00.00% | View details for Wedbush rating of argenex (NASDAQ:ARGX) on 6/11/2026 |
CGEM Cullinan Therapeutics | $17.10
| 6/11/2026 | | Reiterated Rating | $37.00 | Outperform | 00.00% | View details for Wedbush rating of Cullinan Therapeutics (NASDAQ:CGEM) on 6/11/2026 |
RBRK Rubrik | $73.17 -0.1% | 6/11/2026 | | Reiterated Rating | $90.00 | Outperform | 00.00% | View details for Wedbush rating of Rubrik (NYSE:RBRK) on 6/11/2026 |
DDOG Datadog | $246.86
| 6/10/2026 | | Boost Price Target | $220.00 ➝ $260.00 | Outperform | 00.00% | View details for Wedbush rating of Datadog (NASDAQ:DDOG) on 6/10/2026 |
IRON Disc Medicine | $74.12
| 6/10/2026 | | Reiterated Rating | $88.00 | Outperform | 00.00% | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 6/10/2026 |
NICE NiCE | $90.26
| 6/10/2026 | | Lower Price Target | $120.00 ➝ $100.00 | Neutral | 00.00% | View details for Wedbush rating of NiCE (NASDAQ:NICE) on 6/10/2026 |
RNAC Cartesian Therapeutics | $7.88
| 6/10/2026 | | Reiterated Rating | $38.00 | Outperform | 00.00% | View details for Wedbush rating of Cartesian Therapeutics (NASDAQ:RNAC) on 6/10/2026 |
VFS VinFast Auto | $2.85
| 6/10/2026 | | Reiterated Rating | $6.00 | Outperform | 00.00% | View details for Wedbush rating of VinFast Auto (NASDAQ:VFS) on 6/10/2026 |